Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M47.4Revenue $M0.5Net Margin (%)-5,215.6Altman Z-Score-4.8
Enterprise Value $M24.9EPS $-1.3Operating Margin %-4,951.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-5,215.6Higher ROA y-yY
Price/Book1.610-y EBITDA Growth Rate %-12.3Quick Ratio3.2Cash flow > EarningsY
Price/Sales83.45-y EBITDA Growth Rate %-37.2Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-38.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-75.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M23.0ROIC % (ttm)-461.9Gross Margin Increase y-yN

Gurus Latest Trades with CLSN

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CLSN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CLSN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EGWU, Inc. fka EGEN, Inc.10% Owner 2015-08-17Sell10,000$2.19-5.94 view
EGWU, Inc. fka EGEN, Inc.10% Owner 2015-08-13Sell20,000$2.23-7.62 view
Tardugno Michael HCEO 2015-08-10Buy5,000$2.29-10.04 view
EGWU, Inc. fka EGEN, Inc.10% Owner 2015-08-05Sell10,000$2.26-8.85 view
Martinez Alberto R JrDirector 2015-05-13Buy5,000$2.5-17.6 view
EGWU, Inc. fka EGEN, Inc.10% Owner 2015-02-20Sell199,765$3.3-37.58 view
Fritz Frederick J.Director 2014-12-18Buy4,000$2.34-11.97 view
Hooper Robert WDirector 2014-11-13Buy4,000$2.5-17.6 view
Martinez Alberto R JrDirector 2014-08-15Buy5,000$3.12-33.97 view
Tardugno Michael HCEO 2014-08-15Buy4,000$3.12-33.97 view

Quarterly/Annual Reports about CLSN:

News about CLSN:

Articles On GuruFocus.com
Dead Biotech Plays Surge To Life May 07 2013 
Celsion Corp. (CLSN) CEO Michael H Tardugno buys 6,000 Shares Nov 19 2009 
Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares Aug 17 2009 
Celsion Reports Second Quarter 2009 Financial Results and Business Update Aug 05 2009 
Celsion to Hold Second Quarter 2009 Financial Results Jul 31 2009 
Celsion Corp. (CLSN) CEO Michael H Tardugno buys 3,750 Shares Mar 18 2009 
Celsion Corporation to Hold Conference Call to Discuss Its Announced Japan License Agreement for The Dec 16 2008 
Celsion Corporation Announces Exclusive Japan License Agreement with Yakult Honsha for ThermoDox® Dec 15 2008 

More From Other Websites
CELSION CORP Financials Aug 21 2015
10-Q for Celsion Corp. Aug 13 2015
CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 10 2015
Celsion and myTomorrows Expand ThermoDox® European Early Access Program to Include Patients with... Aug 10 2015
Celsion Corporation Reports Second Quarter 2015 Financial Results and Provides Business Update Aug 10 2015
Celsion Corporation Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in... Aug 06 2015
Celsion Corporation Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in... Aug 06 2015
Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August... Aug 03 2015
Celsion Corp. (CLSN) in Focus: Stock Jumps 5.4% - Tale of the Tape Jul 16 2015
One Reason Celsion (CLSN) Stock Is Soaring Jul 15 2015
Coverage initiated on Celsion by Maxim Group Jul 15 2015
Celsion's Phase II Breast Cancer Study Interim Data Positive - Analyst Blog Jul 07 2015
Celsion Announces Continuing Positive Data from Its Phase 2 DIGNITY Study in Breast Cancer Jul 06 2015
Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8,... Jul 01 2015
CELSION CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 19 2015
Celsion Presents GEN-1 Immunotherapy Phase 1b Results in Recurrent Ovarian Cancer at ASCO 2015 Jun 01 2015
CELSION CORP Files SEC form 8-K/A, Financial Statements and Exhibits May 29 2015
CELSION CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 28 2015
Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering May 28 2015
Celsion Announces Potent, Durable Preclinical Lung Expression Data for Its Novel TheraSilence™ RNA... May 21 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK